跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-337
首页
药物
A-337
A-337
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FCE mRNA capping enzyme compositions, methods and kits
US 11028379 B1
申请人: NEW ENGLAND BIOLABS INC
优先权: 2021
US
5 件公开
Influenza virus vaccines and uses thereof
US 10517941 B2
申请人: JANSSEN VACCINES & PREVENTION BV
优先权: 2013
CN
US
2 件公开
Carboxy-terminal BRCA1 interacting protein
US 6235263 B1
申请人: MYRIAD GENETICS INC
优先权: 2000
US
Crystal structure of chorismate synthase and uses thereof
US 2006211040 A1
申请人: PRIMROSE WILLIAM U
优先权: 2002
US
Orphan GPCR gene 115 for obesity indication
EP 1437595 A1
申请人: HOFFMANN LA ROCHE
优先权: 2002
EP
Association of Protein Polymorphisms With Coronary Heart Disease
US 2007292859 A1
申请人: SANOFI AVENTIS DEUTSCHLAND
优先权: 2004
US
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
US 2008160636 A1
申请人: UNIV DUKE
优先权: 2007
US
Drug-resistant bacteria antagonizing composition and preparation method thereof
CN 104147013 A
申请人: HAINAN HONZ PHARMACEUTICAL CO LTD
优先权: 2013
CN
Genetic Material Manipulation and Cell Line Creation Techniques and Products Thereof
US 2015218587 A1
申请人: GENEFORGE LTD
优先权: 2014
US
A compound guanidine disinfectant liquid and a preparation method thereof
CN 109172661 A
申请人: AUSTRALIA JIE LIAONING PHARMACEUTICAL TECH CO LTD
优先权: 2018
CN
第 1 / 2 页
上一页
下一页
药物
反馈